On April 25, Dalian Bio-Chem Company Limited(603360) disclosed the annual report of 2021, realizing an operating revenue of 1.006 billion yuan, a year-on-year increase of 34.25%; The net profit attributable to shareholders of listed companies was 250 million yuan, a year-on-year increase of 12.96%.
In 2021, the company’s main business, isothiazolinone industrial fungicides, saw a year-on-year increase in sales prices and the release of new production capacity, which significantly enhanced the company’s profitability. The company paid close attention to the awareness of safety and environmental protection production, implemented the strategy of double increase in production and marketing, and improved the level of production and operation management, realizing the double growth of operating revenue and net profit.
The company has been deeply engaged in the isothiazolinone Industrial Bactericide industry for nearly 20 years, and has become the largest isothiazolinone Industrial Bactericide technical agent manufacturer in Asia. During the reporting period, the construction of phase III project of songmudao branch was completed and put into trial production in September 2021. The production capacity improvement process was in line with expectations. At present, the company has a production capacity of technical agents of more than 40000 tons / year, which further consolidated the industry position of the company in the production of technical fungicides of isothiazolinone. The company’s products have obtained the registration of American EPA and European BPR, and have the access qualification for export to major overseas markets. With reliable product quality and stable supply capacity, the company has established stable long-term cooperative relations with Langsheng chemical, oshada, Troy and other core customers at home and abroad, and has become a high-quality partner of major downstream sterilization and mildew prevention service enterprises.
In 2022, the company will adhere to the general tone of seeking progress while maintaining stability. First, continue to consolidate the foundation of safe production, maintain production continuity and high load, and strengthen the company’s core competitiveness; Second, give play to the advantages of scale and technology to stabilize the leading position in many aspects; Third, strengthen the fine management of production and operation, and promote cost reduction and efficiency increase.
